Does colorectal cancer clinical advancement and surgical treatment affect platelet factor 4 concentration;Czy stopień zaawansowania raka jelita grubego i leczenie chirurgiczne wpływaja̧ na zmiany stȩżenia czynnika płytkowego 4

Polski Merkuriusz Lekarski

Volumn 17, Issue 102, 2004, Pages 575-578

  Dymicka Piekarska, Violetta ^a   Butkiewicz, Anna ^a   Kemona, Halina ^a   Gryko, Mariusz ^b   Mantur, Maria ^a  

^a Zaklad Laboratoryjnej Diagnostyki K   (Poland)

^b II Klinika Chirurgii Ogolnej SPSK A

Author keywords

Blood platelet; Colorectal cancer; Platelet factor 4

Indexed keywords

THROMBOCYTE FACTOR 4;

ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; METASTASIS; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT;

COLORECTAL NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PLATELET ACTIVATION; PLATELET FACTOR 4; POSTOPERATIVE CARE; PREOPERATIVE CARE; TREATMENT OUTCOME;

EID: 11844289559     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Abbasciano V. i wsp.: Platelet activation and fibrinolysis in large bowel cancer. Oncology, 1995, 52, 881-384.
2. Abbasciano V. i wsp.: Pre-and postsurgery activation of blood coagulation in gastric and large bowel cancers, diagnostic, therapeutic and prognostic hints. Oncology, 1990, 47, 261-266.
3. Abbasciano V. i wsp.: Usefulness of coagulation markers in staging of gastric cancer. Cancer Detect. Prevent., 1995, 19, 4, 331-336.
4. Aigner S. i wsp.: CD 24, a mucin-type glycoprotein, as a ligand for P-selectin on human tumor cells. Blood, 1997, 89, 3385-3395.
5. Al-Mondhiry H. Beta- thromboglobulin and platelet factor 4 in patients with cancer, correlation with the stage of disease and the effect of chemotherapy. Am. J. Hematol., 1983, 14, 105-109.
6. Borsig L. i wsp.: Heparin and cancer revisited, mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc. Natl. Acad. Sci., USA 2001, 98, 3352-3357.
7. Clemetson K.J. i wsp.: Platelet adhesion and aggregation receptors. Chapter 8. Handbook of experimental pharmacology. 1997, 126, 155-179.
8. Dudek A.Z. i wsp.: Platelet factor 4 binds to glycanated forms of thrombomodulin and protein C. J. Biol. Chem., 1997, 272, 50, 31785-31792.
9. Grignani G. i wsp.: The possible role of blood platelets in tumour growth and dissemination. Haematologica, 1986, 71, 245.
10. Honn K.V. i wsp.: Platelets and cancer metastasis, a casual relationship? Cancer Metastasis Rev., 1992, 11 , 3-4, 325-351.
11. Kaplan K.L. et al Plasma levels of B-TG and platelet factor 4 as indices of platelet activation in vivo. Blood, 1981, 57, 199-201.
12. Kaushansky K. Thrombopoietin and the physiology of platelet production. Leukemia Res., 1996, 20, 9, 705-707.
13. Klinger M.H.F. platelets and inflammation. Anat. Embryol., 1997, 196, 1-11.
14. Levine S.P. i wsp.: Platelet factor 4 and platelet secreted proteoglycan, immunologic characterization by crossed immunoelectrophoresis. Blood, 1990, 75,4, 920-910.
15. Matzdorf A.C. Comparison of beta-thromboglobulin, flow cytometry, and platelet aggregometry to study platelet activation. Haemostasis, 1996, 26, 98-106.
16. Rickles F.R. i wsp.: Molecular basis for the relationship between thrombosis and cancer. Thromb. Res., 2001, 102, V215.
17. Seyfert UT.. i wsp.: Platelet-tumor cell interaction. Folia Haematologica, 1990, 117, 685.
18. Stocki W. i wsp.: Ocena aktywnoṡci plytek krwi u chorych z zaawansowanym rakiem żoła̧dka. Pol. Przegl. Chir., 1999, 2, 383-385.
19. Stringer S.E. i wsp.: Specific binding of the chemokine platelet factor 4 to heparan sulfate. J. Biol. Chem., 1997, 272, 1-7.
20. Zucker M.B. i wsp.: Platelet factor 4, production, structure and physiologic and immunologic action. Proc. Soc. Exp. Biol. Med., 1991, 198, 693-702
21. Zucker-Franklin D. Effect of cytokines on the development of megacaryocytes and platelets. Stem. Cells, 1996, 15, 237-255.